We are thrilled to share that our portfolio company, Eagle Genomics, has appointed the distinguished former Microsoft executive, Dr. Victoria Kimonides, as their new CEO. 🚀 👩💼
Upon her appointment, Dr. Kimonides expressed her enthusiasm about Eagle Genomics’ potential to significantly impact large corporations by curating and analysing their extensive investments in microbiome research. She envisions aiding these companies in commercialising their research and creating sustainable solutions beneficial to both individuals and the environment. 🌏
In addition to this leadership change, Eagle Genomics has announced a successful fundraising round, securing over $4 million. This takes their total funding raised in the last year past the $25 million mark!
For more details, you can read the full article on Business Weekly newspaper HERE.